Tegretol and Restasis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tegretol (carbamazepine) and Restasis (cyclosporine). Common drug interactions include blister among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Tegretol and Restasis. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Tegretol?

Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 45,969 Tegretol users. Check the latest studies of Tegretol.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

On Aug, 08, 2026

61 people who take Tegretol and Restasis together, and have interactions are studied.

Tegretol and Restasis drug interactions.

What are the common drug interactions of Tegretol and Restasis, by gender? *:

female:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Sinusitis (inflammation of sinus)
Cystitis (inflammation of the wall of the bladder)
Dysarthria (speech disorder)
Ear infection
Gait disturbance
Muscular weakness (muscle weakness)
Urinary tract infection
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Ataxia (loss of full control of bodily movements)

male:

Back pain
Eye irritation
Mitral valve incompetence (inefficient heart valve)
Mobility decreased (ability to move is reduced)
Pain
Tricuspid valve incompetence (inefficient heart valve)
Urinary tract infection
Vision blurred
Vomiting
Eye pain

What are the common drug interactions of Tegretol and Restasis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
Cholecystitis chronic (long lasting infection of gallbladder)
Injury
Pain
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Appendix disorder

30-39:

n/a

40-49:

Haemolytic anaemia (anaemia due to haemolysis)
Malignant neoplasm of islets of langerhans (cancer tumour of pancreas)
Thyroid cancer
Sepsis (a severe blood infection that can lead to organ failure and death)
Visual acuity reduced (reduced clearness of vision)

50-59:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Ataxia (loss of full control of bodily movements)
Balance disorder
Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Dysarthria (speech disorder)
Gait disturbance
Muscular weakness (muscle weakness)
Neuropathy peripheral (surface nerve damage)
Spasmodic dysphonia (a voice disorder characterized by involuntary movements or spasms of one or more muscles of the larynx)

60+:

Cystitis (inflammation of the wall of the bladder)
Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
Sinusitis (inflammation of sinus)
Urinary tract infection
Eye irritation
Tooth abscess (pus formation in tooth)
Tooth fracture
Upper respiratory tract infection
Drug hypersensitivity
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 10 people, 16.39%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 13.11%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 9.84%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 9.84%
Nausea (feeling of having an urge to vomit): 6 people, 9.84%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 9.84%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.84%
Urinary Tract Infection: 5 people, 8.20%
Stress And Anxiety: 5 people, 8.20%
Pain: 5 people, 8.20%

* Approximation only. Some reports may have incomplete information.

Do you take Tegretol and Restasis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously